CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 355 filers reported holding CYTOKINETICS INC in Q2 2024. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,754,730 | +153.6% | 198,500 | +52.7% | 2.46% | +142.3% |
Q2 2023 | $4,240,600 | -41.9% | 130,000 | -37.3% | 1.01% | -53.6% |
Q1 2023 | $7,301,925 | -36.3% | 207,500 | -17.0% | 2.19% | -45.1% |
Q4 2022 | $11,455,000 | -10.1% | 250,000 | -4.9% | 3.98% | -24.3% |
Q3 2022 | $12,742,000 | +7.2% | 263,000 | -13.1% | 5.26% | -1.8% |
Q2 2022 | $11,885,000 | -20.6% | 302,500 | -25.6% | 5.36% | +15.3% |
Q1 2022 | $14,963,000 | -43.4% | 406,500 | -29.9% | 4.65% | -17.1% |
Q4 2021 | $26,436,000 | +27.5% | 580,000 | 0.0% | 5.61% | +44.8% |
Q3 2021 | $20,729,000 | +80.6% | 580,000 | 0.0% | 3.87% | +103.1% |
Q2 2021 | $11,478,000 | -14.9% | 580,000 | 0.0% | 1.91% | -3.8% |
Q1 2021 | $13,491,000 | +11.4% | 580,000 | -0.5% | 1.98% | +25.3% |
Q4 2020 | $12,111,000 | +167.9% | 582,800 | +179.1% | 1.58% | +79.0% |
Q3 2020 | $4,521,000 | -36.7% | 208,800 | -31.1% | 0.88% | -38.7% |
Q2 2020 | $7,143,000 | – | 303,050 | – | 1.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,721,888 | $46,633,000 | 5.62% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 107,139 | $873,000 | 0.62% |
Virtus ETF Advisers LLC | 42,645 | $348,000 | 0.44% |
SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $1,712,000 | 0.20% |
LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $21,581,000 | 0.20% |
WASATCH ADVISORS LP | 1,679,778 | $13,690,000 | 0.18% |
PINNACLE ASSOCIATES LTD | 877,575 | $7,152,000 | 0.14% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 107,728 | $878,000 | 0.12% |
Tekla Capital Management LLC | 350,300 | $2,855,000 | 0.11% |
Financial Gravity Companies, Inc. | 9,302 | $86,000 | 0.10% |